Publicacións nas que colabora con Clara Álvarez Villamarín (16)

2024

  1. Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

    Nature Communications

  2. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

    Nature Communications

  3. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Correction: RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas (Oncogene, (2021), 40, 45, (6354-6368), 10.1038/s41388-021-02009-8)

    Oncogene

2022

  1. The Inflammatory Pattern of Chronic Limb-Threatening Ischemia in Muscles: The TNF-α Hypothesis

    Biomedicines, Vol. 10, Núm. 2

2021

  1. Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas

    Clinical Endocrinology, Vol. 94, Núm. 5, pp. 811-819

  2. RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas

    Oncogene, Vol. 40, Núm. 45, pp. 6354-6368

2020

  1. GFRα 1-2-3-4 co-receptors for RET Are co-expressed in Pituitary Stem Cells but Individually Retained in Some Adenopituitary Cells

    Frontiers in Endocrinology, Vol. 11

2019

  1. Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly

    EBioMedicine, Vol. 43, pp. 537-552

2017

  1. Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer

    Oncogene, Vol. 36, Núm. 5, pp. 652-666

2013

  1. Humanized medium (h7H) allows long-term primary follicular thyroid cultures from human normal thyroid, benign neoplasm, and cancer

    Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 6, pp. 2431-2441

2012

  1. Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET/GFRA3 receptors

    Journal of Clinical Endocrinology and Metabolism, Vol. 97, Núm. 1

  2. Defining stem cell types: Understanding the therapeutic potential of ESCs, ASCs, and iPS cells

    Journal of Molecular Endocrinology, Vol. 49, Núm. 2

  3. Direct promoter induction of p19Arf by Pit-1 explains the dependence receptor RET/Pit-1/p53-induced apoptosis in the pituitary somatotroph cells

    Oncogene, Vol. 31, Núm. 23, pp. 2824-2835

2010

  1. Expression of exogenous proteins and short hairpin RNAs in human primary thyrocytes

    Analytical Biochemistry, Vol. 400, Núm. 2, pp. 219-228

  2. Functional role of the RET dependence receptor, GFRa co-receptors and ligands in the pituitary

    Frontiers of Hormone Research, Vol. 38, pp. 127-138